Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2
3(75.0%)
Phase 1
1(25.0%)
4Total
Phase 2(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07386730Phase 1Not Yet Recruiting

A Study of Psychedelics in Healthy Older Adults With Low Well-being

Role: lead

NCT03865615Phase 2Withdrawn

Oxytocin on Approach Bias and Craving

Role: lead

NCT02742532Phase 2Completed

Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress

Role: lead

NCT02740582Phase 2Completed

Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users

Role: lead

All 4 trials loaded